Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | ACVR1 | Q04771 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MPI | P34949 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21892099 | 0.76 | L3MBTL1 (0.46) | L3MBTL1IP6K1KDM4EACVR1 | |
| SCHEMBL19185810 | 0.74 | L3MBTL1 (1.00) | L3MBTL1IP6K1KDM4EHTTMAPT | |
| SCHEMBL7222755 | 0.71 | PARP1 (0.56) | EGFRIP6K1SMN1; SMN2MAPTNPSR1 | |
| SCHEMBL20127277 | 0.70 | EGFR (0.52) | L3MBTL1EGFRMAPTLMNAPOLB | |
| SCHEMBL4252815 | 0.69 | L3MBTL1 (0.59) | L3MBTL1IP6K1KDM4ESMN1; SMN2ACVR1 | |
| SCHEMBL15680577 | 0.68 | L3MBTL1 (0.50) | L3MBTL1IP6K1KDM4EACVR1 | |
| SCHEMBL1115720 | 0.68 | MAPT (0.47) | KDM4ESMN1; SMN2RAB9AHTTMAPT | |
| SCHEMBL1115798 | 0.67 | MAPT (0.76) | L3MBTL1KDM4ESMN1; SMN2HTTMAPT | |
| SCHEMBL9679622 | 0.67 | MAPT (0.50) | L3MBTL1KDM4ESMN1; SMN2GAARAB9A | |
| SCHEMBL3881328 | 0.67 | L3MBTL1 (0.74) | L3MBTL1IP6K1KDM4EHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| US-8262949-B2 | Long wavelength shifted benzotriazole uv-absorbers and their use | BASF SE (DE) | 2012-09-11 | — | — | US | disclosed |
| EP-2032577-B1 | LONG WAVELENGTH SHIFTED BENZOTRIAZOLE UV-ABSORBERS AND THEIR USE | BASF SE (DE) | 2011-02-02 | — | — | EP | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | CIBA CORPORATION | 2010-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100163813-A1 | Long wavelength shifted benzotriazole uv-absorbers and their use | SULT1A1, GABBR1, TPMT | L3MBTL1 3864/4885EGFR 4053/4885IP6K1 3586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.